Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Dextrose for Chronic Cystitis
NCT04821882Completed
- Sponsor
- National Defense Medical Center
- Start
- May 2019
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
Open-label trial of dextrose in bladder pain syndrome (BPS) and interstitial cystitis (IC) (2 arms), sponsored by National Defense Medical Center. Primary endpoints: Urinary Voiding Symptoms Analysis at 3 days, Global Response Assessment up to 7 months and 7 more. Started May 2019; status: completed.
02
Drugs
dextrose
03
Conditions
bladder pain syndrome (BPS)interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT04821882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821882.